thymoquinone has been researched along with Hyperlipidemias in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, Y; Wang, F; Wu, Y; Yao, W; Yu, D; Zhang, X | 1 |
| Dong, M; Guo, Y; Pei, ZW; Wang, F; Zhang, Q; Zhu, HL | 1 |
| Abu-Yousef, IA; Majdalawieh, AF; Yousef, SM | 1 |
| Abdel-Naim, AB; Abdel-Wahab, MH; Badary, OA; Hamada, FM | 1 |
1 review(s) available for thymoquinone and Hyperlipidemias
| Article | Year |
|---|---|
Thymoquinone, a major constituent in Nigella sativa seeds, is a potential preventative and treatment option for atherosclerosis.
Topics: Animals; Atherosclerosis; Benzoquinones; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Hyperlipidemias; Inflammation; Nigella sativa; Oxidative Stress; Seeds; Treatment Outcome | 2021 |
3 other study(ies) available for thymoquinone and Hyperlipidemias
| Article | Year |
|---|---|
Protective role of thymoquinone in hyperlipidemia-induced liver injury in LDL-R
Topics: Animals; Chemical and Drug Induced Liver Injury, Chronic; Cholesterol; Hyperlipidemias; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease | 2023 |
Thymoquinone Protects against Hyperlipidemia-Induced Cardiac Damage in Low-Density Lipoprotein Receptor-Deficient (LDL-R
Topics: Animals; Anti-Inflammatory Agents; Benzoquinones; Cardiotonic Agents; Cytokines; Diet, High-Fat; Extracellular Signal-Regulated MAP Kinases; Hyperlipidemias; Inflammation Mediators; Lipid Metabolism; Male; Mice; Models, Biological; Myocardium; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyroptosis; Receptors, LDL; RNA, Messenger | 2020 |
The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats.
Topics: Acetylglucosaminidase; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzoquinones; Body Weight; Doxorubicin; Hyperlipidemias; Kidney Diseases; Kidney Function Tests; Male; Proteinuria; Rats; Rats, Wistar; Serum Albumin; Sulfhydryl Compounds; Thiobarbituric Acid Reactive Substances; Urea | 2000 |